Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $2.1B | $1.6B | $1.7B | $343.3M | $371.5M | |
| Gross Profit | $1.1B | $888.7M | $942.6M | $212.1M | $230.6M | |
| Operating Income | $172.8M | $198.1M | $174.3M | $38.2M | $83.7M | |
| EBITDA | $328M | $251.3M | $230.2M | $48.4M | $91.8M | |
| Diluted EPS | $1.63 | $1.46 | -$10.61 | $0.18 | -$1.86 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1.2B | $1.2B | $1.3B | $1B | |
| Total Assets | $1.8B | $3.1B | $3B | $3.1B | $1.8B | |
| Current Liabilities | $228.3M | $587.3M | $578.8M | $637.6M | $369.7M | |
| Total Liabilities | $298.6M | $1.8B | $1.7B | $1.6B | $1B | |
| Total Equity | $1.5B | $1.3B | $1.3B | $1.5B | $810M | |
| Total Debt | $27.5M | $1B | $982.4M | $838.4M | $578.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $10.4M | $223M | $207.8M | $25.6M | $56.8M | |
| Cash From Investing | -$78.7M | -$60M | $267.3M | -$13.5M | $282.3M | |
| Cash From Financing | -$25.5M | -$155.4M | -$312.6M | -$1.6M | -$218.4M | |
| Free Cash Flow | -$58.4M | $170.6M | $188.7M | $16.3M | $49.7M | |
Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. It operates through the following segments: Healthcare and Non-Healthcare. The Healthcare segment develops, manufactures, and markets a variety of noninvasive monitoring technologies and hospital automation solutions and therapeutics. The Non-Healthcare segment designs, develops, manufactures, markets and sells a broad portfolio of premium, high-performance audio products and services. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
In the current month, MASI has received 4 Buy ratings 3 Hold ratings, and 0 Sell ratings. The MASI average analyst price target in the past 3 months is $183.75.
According to analysts, the consensus estimate is that Masimo Corp. share price will rise to $183.75 per share over the next 12 months.
Analysts are divided on their view about Masimo Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Masimo Corp. is a Sell and believe this share price will drop from its current level to $162.00.
The price target for Masimo Corp. over the next 1-year time period is forecast to be $183.75 according to 7 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Masimo Corp. is a Buy. 4 of 7 analysts rate the stock a Buy at this time.
You can purchase shares of Masimo Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Masimo Corp. shares.
Masimo Corp. was last trading at $133.46 per share. This represents the most recent stock quote for Masimo Corp.. Yesterday, Masimo Corp. closed at $133.28 per share.
In order to purchase Masimo Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.